🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Long term management of iTTP

Target is paying its employees more than we pay our residents. Assume a resident is making $65,000/yr working 80 hrs/week with 3 weeks PTO. That means a resident is only making $16.58 for each hour worked. ($65k/3,920 hours) Target will pay you $17.25/hr and you don’t need 8

Are you interested in Hemophilia B research? ATHN has a research study about treatment and safety of Coagulation Factor IX (Recombinant) GlycoPEGylated (Rebinyn®). If you join the study, you can help us learn more! gothemophiliab.com/hemophiliab.ht…

Castleman Disease isn’t cancer—but can act like it. It’s a rare lymphoproliferative disorder with two main types: 🔹 Unicentric – localized, often curable with surgery 🔹 Multicentric – systemic, can be life-threatening MCD- Think cytokine storm, not lymphoma! #MedTwitter

Screening women of reproductive age for iron deficiency and treating at a ferritin threshold of < 25 mcg/L is highly cost effective. Brought to my attention today by Peter Tonzi who reviewed the study PMID: 40235279 (available ahead of print) at new patient conference. LUV IT!

I am looking for patient & public involvement on the subject of heparin induced thrombocytopenia. Looking for people who have lived experience of cardiac surgery (either yourself or a close relative) to help shape future research on a complication of heparin use during surgery.

How is joint ultrasound being used in hemophilia care around the world? We want to hear from YOU! 👩‍⚕️Who is performing it 🧠What training exists (or is missing!) 🚧What barriers are limiting access We’re looking for insights from HCPs in hemophilia care: redcap.isth.org/surveys/?s=9NY…

Hemophilia & Thrombosis Research Society (HTRS) email has been compromised. A phishing email is being sent from their account asking to fill out a RFP in a password protected pdf. Please do not open it Hemostasis and Thrombosis Research Society

The remarkable story of Velcade. In the year 2000, a few of us attended an angiogenesis meeting in Boston. We were there to discuss thalidomide But a side meeting that evening led to trial that went on to get Velcade FDA approved for myeloma. NEJM Story in thread.

Mind boggling!

Mobility is one of the most important - and most overlooked - ICU interventions. One challenge is its isn’t always obvious what mobility level a patient has achieved. I built these “flip books” using the JH-HLM scale to indicate (& motivate) mobility in every patients room.

Academic US physicians.. are you advising your trainees interested in a career in clinical research to.. (Consider reposting to get a large response) #neurotwitter #AcademicTwitter #MedTwitter

A big step forward vs cancer nature.com/articles/d4158…

So proud of this study and honored to be the senior author! What we’ve learned: The Fellow On Call and TwoOncDocs should be integrated into our heme/onc fellow education! 🔥 Link to this study: ascopubs.org/doi/10.1200/OP…

Non-invasive ventilation flash back: Quotes that did not age well: The former editor-in-chief of "Respiratory Care" wrote in 1977 in a letter to CHEST® Journal: "A patient who is sick enough to need CPAP is sick enough to need an endotracheal tube"

What a game! Gukesh D 🥂💯

It is both chainless and puts much less load on the knees...

The Rowley Lab (plateletlab.com) is hiring post-docs! Are you interested in mitochondria, megakaryocytes, platelets, hematopoietic stem cells, or CRISPR/CAS9 functional screens? Message me or apply at utah.peopleadmin.com/postings/183682 .

Academic docs who actually want to do research are getting squeezed HARD. The system says it values discovery. The paychecks say: “More RVUs, less thinking.” Let’s talk about the quiet collapse of the research track in medicine.

Someone at Novo Nordisk failed to pay a $450 maintenance fee, which would have kept its patent on Ozempic in force for another two years... A very expensive mistake!